Arbutin attenuates monosodium L-glutamate induced neurotoxicity and cognitive dysfunction in rats

Neurochem Int. 2021 Dec:151:105217. doi: 10.1016/j.neuint.2021.105217. Epub 2021 Oct 25.

Abstract

Excitotoxicity, oxidative stress, and neuro-inflammation underlie the pathogenesis of neurodegenerative brain disorders. Although L-glutamate is the prime excitatory neurotransmitter involved in diverse brain functions, however, overabundance at synapse can activate cell death mechanisms. Previous studies indicate that arbutin affords relief in metabolic, cardiovascular, and gastrointestinal disorders. Recently, arbutin showed benefits in animal models of epilepsy, Parkinson's disease, and Alzheimer's disease that further expanded its therapeutic potential against brain disorders. In the present study, we aimed to evaluate the potential of arbutin against monosodium L-glutamate (MSG) neurotoxicity in rats. Wistar rats (male, 180-200 g) were administered MSG (4 mg/kg) and arbutin (50 and 100 mg/kg) intraperitoneally for 21 days. Cognitive functions were assessed using elevated plus maze and novel object recognition task. Biochemical parameters of oxidative stress, tumour necrosis factor-α (TNF-α), γ-amino butyric acid (GABA), acetylcholinesterase (AChE) activity, lactate dehydrogenase (LDH), and intracellular cation-levels (Na+, Ca2+, K+) were determined using whole brain. Administration of MSG augmented cation-levels, oxidative stress, inflammation, AChE, and LDH activities, and decreased GABA levels in the brain. Arbutin (50 and 100 mg/kg, i.p.) significantly decreased these biochemical disturbances in the brain of MSG administered rats. Behavioural results showed that MSG triggered cognitive deficits in rats that were significantly attenuated by arbutin. Histopathological findings in hippocampus and cortex revealed neuroprotective outcome of arbutin treatments against MSG. MK-801 and N(G)-nitro-L-arginine methyl ester (L-NAME) enhanced memory and neuroprotective effects in rats treated with arbutin and MSG. Arbutin may afford therapeutic advantages in neurodegenerative brain disorders by suppressing the excitotoxic pathways.

Keywords: Arbutin; Calcium; GABA; L-glutamate; Memory; Neurodegeneration.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Arbutin / metabolism
  • Arbutin / pharmacology*
  • Cognitive Dysfunction / chemically induced
  • Cognitive Dysfunction / drug therapy*
  • Cognitive Dysfunction / metabolism
  • Disease Models, Animal
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Male
  • Memory Disorders / chemically induced
  • Memory Disorders / drug therapy
  • Neuroprotective Agents / pharmacology
  • Neurotoxicity Syndromes / drug therapy*
  • Neurotoxicity Syndromes / metabolism
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Wistar
  • Sodium Glutamate / toxicity*

Substances

  • Neuroprotective Agents
  • Arbutin
  • Acetylcholinesterase
  • Sodium Glutamate